The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 52 | 21.2x | 20.1x | Near average | |
Growth | 39 | 1.1% | 5.6% | Near average | |
Quality | 46 | 10.3% | 7.6% | Near average | |
Safety | 56 | 1.3x | 0.4x | Near average | |
Capital Return | 49 | 0.30% | 2.19% | Near average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
Core Laboratories N.V. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Core Laboratories N.V. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
Core Laboratories stock has shown a state of extreme stability in price forecasts recently, with the average price target settling at $25 without any change over the (1, 7, 30-day) periods. However, the data reflects a wide gap (Dispersion) between the price target floor of $17 and the ceiling of $32, indicating a variance in the fair value estimation of the stock despite the stability of the current consensus.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.